We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
HDT Bio and its development partner in India, Gennova Biopharmaceuticals, have started dosing healthy subjects with the Covid-19 vaccine in a Phase I/II trial in the country.